Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity

In a preliminary communication we reported [(Tetrahedron Lett. 31, 619 (1990)] that acetyl hypofluorite can be used efficiently to introduce fluorine regiospecifically (ortho to OH) into the phenolic ring of tyrosine‐containing peptides. This procedure has been applied to the fluorination of a numbe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International Journal of Peptide and Protein Research 1991-05, Vol.37 (5), p.430-439
Hauptverfasser: LABROO, VIRENDER M., HEBEL, DAVID, KIRK, KENNETH L., COHEN, LOUIS A., LEMIEUX, CAROLE, SCHILLER, PETER W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 439
container_issue 5
container_start_page 430
container_title International Journal of Peptide and Protein Research
container_volume 37
creator LABROO, VIRENDER M.
HEBEL, DAVID
KIRK, KENNETH L.
COHEN, LOUIS A.
LEMIEUX, CAROLE
SCHILLER, PETER W.
description In a preliminary communication we reported [(Tetrahedron Lett. 31, 619 (1990)] that acetyl hypofluorite can be used efficiently to introduce fluorine regiospecifically (ortho to OH) into the phenolic ring of tyrosine‐containing peptides. This procedure has been applied to the fluorination of a number of μ‐selective opioid peptides derived from dermorphin. While the procedure can be used even when the side chains of Arg, Lys, and Tyr are left unprotected, the sulfoxide of a Met(O)‐containing analogue was oxidized to sulfone faster than fluorination of the phenolic ring. This method can also be used when the peptide is attached to Merrifield resin. Thus, Tyr(3‐F)‐d‐Ala‐Phe‐Gly‐NH2 and Tyr(3‐F)‐d‐Arg‐Phe‐Lys‐NH2 (F‐DALDA) have been prepared, purified, and characterized. Affinities of these fluorinated peptides for both μ‐and δ‐opioid receptors are reduced (two‐ to nine‐fold) relative to their nonfluorinated analogues, but their selectivity for μ‐opioid receptors is not significantly altered. Similarly, the in vitro biological potencies (GPI and MVD assays) of the fluorinated analogues are reduced (two‐ to seven‐fold) relative to their nonfluorinated parent peptides. Thus, F‐DALDA, which has high affinity (K δ= 15.2nM) and selectivity (K δ/K δ= 5390) for μ‐opioid receptors, has potential use in biochemical studies which utilize 19F or 18F‐ labeled compounds.
doi_str_mv 10.1111/j.1399-3011.1991.tb00758.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72132302</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72132302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4390-b823e615ed50fdad80c29e385e66ff3afaf19cd73f2eac99102a7f19c978add03</originalsourceid><addsrcrecordid>eNqVUcuO0zAUtRBoKAOfgGSxYEWCHSexwwZBywzz0CAhHkvLta_BJY2L7UL7E_PNOE01LBFe2Ff3PK58D0LPKClpPi9XJWVdVzBCaUm7jpZpSQhvRLm7h2Z30H00I6zlhWCcP0SPYlwRwmrGqxN0QltBBCMzdLtwAXTC0Oc7-M131zuNbb_1wQ0qOT9gb3HaBx_dANgN2EBY-5CJA1aD6v23LcRcGexSxGDt6JZVS-cz5rTqsdLJ_XJp_wLnUbBJPmBlrRty6yCMh-EHymP0wKo-wpPje4o-n737NH9fXH84v5i_uS50zTpSLEXFoKUNmIZYo4wguuqAiQba1lqmrLK004YzW4HSeUOkUnxsdVwoYwg7Rc8n303wP_MHkly7qKHv1QB-GyWvKKsYqf5JpG1bi7buMvHVRNR5VTGAlZvg1irsJSVyTE2u5BiNHKORY2rymJrcZfHT45Ttcg3mr3SKKeOvJ_y362H_H85y_naxqA8OxeTgYoLdnYMKP2TLGW_k15tzeXl5c_WRki-SsT_TbLs-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16648649</pqid></control><display><type>article</type><title>Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity</title><source>MEDLINE</source><source>Wiley Journals</source><creator>LABROO, VIRENDER M. ; HEBEL, DAVID ; KIRK, KENNETH L. ; COHEN, LOUIS A. ; LEMIEUX, CAROLE ; SCHILLER, PETER W.</creator><creatorcontrib>LABROO, VIRENDER M. ; HEBEL, DAVID ; KIRK, KENNETH L. ; COHEN, LOUIS A. ; LEMIEUX, CAROLE ; SCHILLER, PETER W.</creatorcontrib><description>In a preliminary communication we reported [(Tetrahedron Lett. 31, 619 (1990)] that acetyl hypofluorite can be used efficiently to introduce fluorine regiospecifically (ortho to OH) into the phenolic ring of tyrosine‐containing peptides. This procedure has been applied to the fluorination of a number of μ‐selective opioid peptides derived from dermorphin. While the procedure can be used even when the side chains of Arg, Lys, and Tyr are left unprotected, the sulfoxide of a Met(O)‐containing analogue was oxidized to sulfone faster than fluorination of the phenolic ring. This method can also be used when the peptide is attached to Merrifield resin. Thus, Tyr(3‐F)‐d‐Ala‐Phe‐Gly‐NH2 and Tyr(3‐F)‐d‐Arg‐Phe‐Lys‐NH2 (F‐DALDA) have been prepared, purified, and characterized. Affinities of these fluorinated peptides for both μ‐and δ‐opioid receptors are reduced (two‐ to nine‐fold) relative to their nonfluorinated analogues, but their selectivity for μ‐opioid receptors is not significantly altered. Similarly, the in vitro biological potencies (GPI and MVD assays) of the fluorinated analogues are reduced (two‐ to seven‐fold) relative to their nonfluorinated parent peptides. Thus, F‐DALDA, which has high affinity (K δ= 15.2nM) and selectivity (K δ/K δ= 5390) for μ‐opioid receptors, has potential use in biochemical studies which utilize 19F or 18F‐ labeled compounds.</description><identifier>ISSN: 0367-8377</identifier><identifier>EISSN: 1399-3011</identifier><identifier>DOI: 10.1111/j.1399-3011.1991.tb00758.x</identifier><identifier>PMID: 1680830</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>acetyl hypofluorite ; Amino Acid Sequence ; Analgesics, Opioid - chemical synthesis ; Analgesics, Opioid - metabolism ; analogs ; Animals ; Brain - metabolism ; dermorphin ; dermorphin analogues ; direct electrophilic fluorination ; fluorinated analogues ; fluorination ; Fluorine - metabolism ; fluoropeptides ; Molecular Sequence Data ; Oligopeptides - chemical synthesis ; Oligopeptides - metabolism ; Opioid Peptides ; opioid receptors ; peptide sequencing ; peptide synthesis ; Rats ; receptor selectivity ; Receptors, Opioid - metabolism ; Receptors, Opioid, delta ; Receptors, Opioid, mu ; solid phase peptide synthesis ; tyrosine ; Tyrosine - metabolism</subject><ispartof>International Journal of Peptide and Protein Research, 1991-05, Vol.37 (5), p.430-439</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4390-b823e615ed50fdad80c29e385e66ff3afaf19cd73f2eac99102a7f19c978add03</citedby><cites>FETCH-LOGICAL-c4390-b823e615ed50fdad80c29e385e66ff3afaf19cd73f2eac99102a7f19c978add03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1399-3011.1991.tb00758.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1399-3011.1991.tb00758.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1680830$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LABROO, VIRENDER M.</creatorcontrib><creatorcontrib>HEBEL, DAVID</creatorcontrib><creatorcontrib>KIRK, KENNETH L.</creatorcontrib><creatorcontrib>COHEN, LOUIS A.</creatorcontrib><creatorcontrib>LEMIEUX, CAROLE</creatorcontrib><creatorcontrib>SCHILLER, PETER W.</creatorcontrib><title>Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity</title><title>International Journal of Peptide and Protein Research</title><addtitle>Int J Pept Protein Res</addtitle><description>In a preliminary communication we reported [(Tetrahedron Lett. 31, 619 (1990)] that acetyl hypofluorite can be used efficiently to introduce fluorine regiospecifically (ortho to OH) into the phenolic ring of tyrosine‐containing peptides. This procedure has been applied to the fluorination of a number of μ‐selective opioid peptides derived from dermorphin. While the procedure can be used even when the side chains of Arg, Lys, and Tyr are left unprotected, the sulfoxide of a Met(O)‐containing analogue was oxidized to sulfone faster than fluorination of the phenolic ring. This method can also be used when the peptide is attached to Merrifield resin. Thus, Tyr(3‐F)‐d‐Ala‐Phe‐Gly‐NH2 and Tyr(3‐F)‐d‐Arg‐Phe‐Lys‐NH2 (F‐DALDA) have been prepared, purified, and characterized. Affinities of these fluorinated peptides for both μ‐and δ‐opioid receptors are reduced (two‐ to nine‐fold) relative to their nonfluorinated analogues, but their selectivity for μ‐opioid receptors is not significantly altered. Similarly, the in vitro biological potencies (GPI and MVD assays) of the fluorinated analogues are reduced (two‐ to seven‐fold) relative to their nonfluorinated parent peptides. Thus, F‐DALDA, which has high affinity (K δ= 15.2nM) and selectivity (K δ/K δ= 5390) for μ‐opioid receptors, has potential use in biochemical studies which utilize 19F or 18F‐ labeled compounds.</description><subject>acetyl hypofluorite</subject><subject>Amino Acid Sequence</subject><subject>Analgesics, Opioid - chemical synthesis</subject><subject>Analgesics, Opioid - metabolism</subject><subject>analogs</subject><subject>Animals</subject><subject>Brain - metabolism</subject><subject>dermorphin</subject><subject>dermorphin analogues</subject><subject>direct electrophilic fluorination</subject><subject>fluorinated analogues</subject><subject>fluorination</subject><subject>Fluorine - metabolism</subject><subject>fluoropeptides</subject><subject>Molecular Sequence Data</subject><subject>Oligopeptides - chemical synthesis</subject><subject>Oligopeptides - metabolism</subject><subject>Opioid Peptides</subject><subject>opioid receptors</subject><subject>peptide sequencing</subject><subject>peptide synthesis</subject><subject>Rats</subject><subject>receptor selectivity</subject><subject>Receptors, Opioid - metabolism</subject><subject>Receptors, Opioid, delta</subject><subject>Receptors, Opioid, mu</subject><subject>solid phase peptide synthesis</subject><subject>tyrosine</subject><subject>Tyrosine - metabolism</subject><issn>0367-8377</issn><issn>1399-3011</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVUcuO0zAUtRBoKAOfgGSxYEWCHSexwwZBywzz0CAhHkvLta_BJY2L7UL7E_PNOE01LBFe2Ff3PK58D0LPKClpPi9XJWVdVzBCaUm7jpZpSQhvRLm7h2Z30H00I6zlhWCcP0SPYlwRwmrGqxN0QltBBCMzdLtwAXTC0Oc7-M131zuNbb_1wQ0qOT9gb3HaBx_dANgN2EBY-5CJA1aD6v23LcRcGexSxGDt6JZVS-cz5rTqsdLJ_XJp_wLnUbBJPmBlrRty6yCMh-EHymP0wKo-wpPje4o-n737NH9fXH84v5i_uS50zTpSLEXFoKUNmIZYo4wguuqAiQba1lqmrLK004YzW4HSeUOkUnxsdVwoYwg7Rc8n303wP_MHkly7qKHv1QB-GyWvKKsYqf5JpG1bi7buMvHVRNR5VTGAlZvg1irsJSVyTE2u5BiNHKORY2rymJrcZfHT45Ttcg3mr3SKKeOvJ_y362H_H85y_naxqA8OxeTgYoLdnYMKP2TLGW_k15tzeXl5c_WRki-SsT_TbLs-</recordid><startdate>199105</startdate><enddate>199105</enddate><creator>LABROO, VIRENDER M.</creator><creator>HEBEL, DAVID</creator><creator>KIRK, KENNETH L.</creator><creator>COHEN, LOUIS A.</creator><creator>LEMIEUX, CAROLE</creator><creator>SCHILLER, PETER W.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M81</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>199105</creationdate><title>Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity</title><author>LABROO, VIRENDER M. ; HEBEL, DAVID ; KIRK, KENNETH L. ; COHEN, LOUIS A. ; LEMIEUX, CAROLE ; SCHILLER, PETER W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4390-b823e615ed50fdad80c29e385e66ff3afaf19cd73f2eac99102a7f19c978add03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>acetyl hypofluorite</topic><topic>Amino Acid Sequence</topic><topic>Analgesics, Opioid - chemical synthesis</topic><topic>Analgesics, Opioid - metabolism</topic><topic>analogs</topic><topic>Animals</topic><topic>Brain - metabolism</topic><topic>dermorphin</topic><topic>dermorphin analogues</topic><topic>direct electrophilic fluorination</topic><topic>fluorinated analogues</topic><topic>fluorination</topic><topic>Fluorine - metabolism</topic><topic>fluoropeptides</topic><topic>Molecular Sequence Data</topic><topic>Oligopeptides - chemical synthesis</topic><topic>Oligopeptides - metabolism</topic><topic>Opioid Peptides</topic><topic>opioid receptors</topic><topic>peptide sequencing</topic><topic>peptide synthesis</topic><topic>Rats</topic><topic>receptor selectivity</topic><topic>Receptors, Opioid - metabolism</topic><topic>Receptors, Opioid, delta</topic><topic>Receptors, Opioid, mu</topic><topic>solid phase peptide synthesis</topic><topic>tyrosine</topic><topic>Tyrosine - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LABROO, VIRENDER M.</creatorcontrib><creatorcontrib>HEBEL, DAVID</creatorcontrib><creatorcontrib>KIRK, KENNETH L.</creatorcontrib><creatorcontrib>COHEN, LOUIS A.</creatorcontrib><creatorcontrib>LEMIEUX, CAROLE</creatorcontrib><creatorcontrib>SCHILLER, PETER W.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International Journal of Peptide and Protein Research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LABROO, VIRENDER M.</au><au>HEBEL, DAVID</au><au>KIRK, KENNETH L.</au><au>COHEN, LOUIS A.</au><au>LEMIEUX, CAROLE</au><au>SCHILLER, PETER W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity</atitle><jtitle>International Journal of Peptide and Protein Research</jtitle><addtitle>Int J Pept Protein Res</addtitle><date>1991-05</date><risdate>1991</risdate><volume>37</volume><issue>5</issue><spage>430</spage><epage>439</epage><pages>430-439</pages><issn>0367-8377</issn><eissn>1399-3011</eissn><abstract>In a preliminary communication we reported [(Tetrahedron Lett. 31, 619 (1990)] that acetyl hypofluorite can be used efficiently to introduce fluorine regiospecifically (ortho to OH) into the phenolic ring of tyrosine‐containing peptides. This procedure has been applied to the fluorination of a number of μ‐selective opioid peptides derived from dermorphin. While the procedure can be used even when the side chains of Arg, Lys, and Tyr are left unprotected, the sulfoxide of a Met(O)‐containing analogue was oxidized to sulfone faster than fluorination of the phenolic ring. This method can also be used when the peptide is attached to Merrifield resin. Thus, Tyr(3‐F)‐d‐Ala‐Phe‐Gly‐NH2 and Tyr(3‐F)‐d‐Arg‐Phe‐Lys‐NH2 (F‐DALDA) have been prepared, purified, and characterized. Affinities of these fluorinated peptides for both μ‐and δ‐opioid receptors are reduced (two‐ to nine‐fold) relative to their nonfluorinated analogues, but their selectivity for μ‐opioid receptors is not significantly altered. Similarly, the in vitro biological potencies (GPI and MVD assays) of the fluorinated analogues are reduced (two‐ to seven‐fold) relative to their nonfluorinated parent peptides. Thus, F‐DALDA, which has high affinity (K δ= 15.2nM) and selectivity (K δ/K δ= 5390) for μ‐opioid receptors, has potential use in biochemical studies which utilize 19F or 18F‐ labeled compounds.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>1680830</pmid><doi>10.1111/j.1399-3011.1991.tb00758.x</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0367-8377
ispartof International Journal of Peptide and Protein Research, 1991-05, Vol.37 (5), p.430-439
issn 0367-8377
1399-3011
language eng
recordid cdi_proquest_miscellaneous_72132302
source MEDLINE; Wiley Journals
subjects acetyl hypofluorite
Amino Acid Sequence
Analgesics, Opioid - chemical synthesis
Analgesics, Opioid - metabolism
analogs
Animals
Brain - metabolism
dermorphin
dermorphin analogues
direct electrophilic fluorination
fluorinated analogues
fluorination
Fluorine - metabolism
fluoropeptides
Molecular Sequence Data
Oligopeptides - chemical synthesis
Oligopeptides - metabolism
Opioid Peptides
opioid receptors
peptide sequencing
peptide synthesis
Rats
receptor selectivity
Receptors, Opioid - metabolism
Receptors, Opioid, delta
Receptors, Opioid, mu
solid phase peptide synthesis
tyrosine
Tyrosine - metabolism
title Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T05%3A11%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20electrophilic%20fluorination%20of%20tyrosine%20in%20dermorphin%20analogues%20and%20its%20effect%20on%20biological%20activity,%20receptor%20affinity%20and%20selectivity&rft.jtitle=International%20Journal%20of%20Peptide%20and%20Protein%20Research&rft.au=LABROO,%20VIRENDER%20M.&rft.date=1991-05&rft.volume=37&rft.issue=5&rft.spage=430&rft.epage=439&rft.pages=430-439&rft.issn=0367-8377&rft.eissn=1399-3011&rft_id=info:doi/10.1111/j.1399-3011.1991.tb00758.x&rft_dat=%3Cproquest_cross%3E72132302%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16648649&rft_id=info:pmid/1680830&rfr_iscdi=true